14
Aug

The latest batch of Israeli biotechs to hit Nasdaq hasn’t been doing so well. But that hasn’t deterred Foamix Pharmaceuticals from joining the tail end of the big biotech rush into the public markets.

…read more

Source: Another Israeli biotech braves choppy IPO waters

    

0 No comments